CompuGroup Medical Acquires VISUS Health IT

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany.

VISUS's key products are JiveX Enterprise PACS, a leading PACS for hospitals and outpatient facilities, JiveX Healthcare Content Management, a cutting-edge vendor neutral archive solution for medical data, and JiveX Healthcare Connect with focus on communicating medical data. As a result of the acquisition, CompuGroup Medical is complementing its portfolio with a well-established and multiple award-winning product suite. For 2020, revenues were amounted to approximately EUR 18.5 million with an adjusted EBITDA of approximately EUR 2.8 million.

"VISUS complements our existing portfolio of products perfectly and we see a lot of opportunities to integrate these solutions with our successful ambulatory and hospital information systems," emphasized Dr. Dirk Wössner, CEO of CompuGroup Medical SE & Co. KGaA. "We are confident that both, existing CGM and VISUS customers, will benefit from this transaction, facilitating the provision of structured medical data at the right place and time and usable by anyone who needs it. VISUS solutions are a key contributor of medical information with the special focus on medical images."

"With this acquisition, we will gain an additional, highly attractive business area, which is very important for most of our customers, and we will significantly increase our installed customer base particularly in the German hospital market. At the same time, we will benefit from a great amount of know-how and expert knowledge from our new colleagues. We are acquiring innovative and strongly growing products here, which have recently been repeatedly honored with several highly prestigious 'Best in KLAS-Awards'," said Hannes Reichl, Managing Director Inpatient and Social Care at CGM.

"We are convinced that with this merger we will continue the success story of VISUS for our team and our customers in the long term. With CGM, we also have the potential to further expand our existing partner network internationally," said Klaus Kleber, Co-Founder of VISUS. Jörg Holstein, likewise Co-Founder of VISUS, added, "We have been partners with CGM for many years and have implemented many successful projects together. We are pleased to become part of the CGM family while maintaining the VISUS identity. CGM is exactly the right partner for us as a global player with home and heart in Germany."

VISUS's customer base today consists of more than 1.500 facilities inpatient as well as outpatient. Today, more than 1.6 million professional users, including doctors, dentists, pharmacies and other health professionals in outpatient and inpatient healthcare facilities trust CompuGroup Medical.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...